Reportlinker.com

Reportlinker.com

April 16, 2008 05:02 ET

High Growth Reported for the Worldwide Market for In Vitro Diagnostic Tests, 6th Edition

LONDON, UNITED KINGDOM--(Marketwire - April 16, 2008) - Reportlinker.com announces that a new market research report related to the Retailing industry is available in its catalogue.

The Worldwide Market for In Vitro Diagnostic Tests, 6th Edition

http://www.reportlinker.com/p087188/The-Worldwide-Market-for-In-Vitro-Diagnostic-Tests-6th-Edition.html

This completely updated edition of Kalorama's comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market statistics and analysis for all areas of IVD, including:

- Point-of-Care

- Clinical Chemistry

- Immunoassays

- Molecular Assays

- Hematology

- Coagulation

- Microbiology and Virology

- Blood Banking

- Histology and Cytology

Market size, growth, share, and geographic distribution, as well as trends in technology development, regulatory and reimbursement issues, clinical care, and business environments are discussed. Projections are made through 2012.

This new 1,100-page edition greatly expands coverage of the field and tracks the most important developments. Expanded or added in this edition are sections on:

- the status of POC and decentralization in lab medicine

- miniaturization and molecularization of devices

- geo-economic and demographic influences on markets

- non-invasive sampling

- greatly expanded market data on PGx and SNP testing

- revamped segmentation for clinical chemistry to include workstations and immunoanalyzers

- more information about more immunoassays

- the renewed interest in microbiology/virology based on resistance and the re-emergence of serious hospital- and community-based organisms

- world blood banking developments

- expanded sections on histology/cytology developments including emerging areas such as tissue microarrays, circulating tumor cells, and genomics-fueled innovation.

In addition, there are now profiles of more than established and emerging players in IVD with profiles of more than 421 companies, from the top tier to emerging and niche competitors to watch.

PRE-PUB ONLY TITLE WILL NOT BE DELIVERED UNTIL MID MAY 2008

NOTE: The 6th Edtion of In Vitro Diagnostics has not yet been published. This is a preliminary Table of Contents Only.

Chapter One: Executive Summary

- Scope and Methodology

- Size and Growth of the Market

- Market Trends

Chapter Two: Introduction

- Lab Medicine Disciplines and Applications

- Market Analysis of IVD Market Segments

- Market Events

- Top Suppliers and Niche Players

- Point of View

Chapter Three: Overview of Global In Vitro Diagnostic Markets

- The Global Community Strives for Regulatory Harmonization

- World Segments of the IVD Market and IVD Market Evolution

-- The United States-A Free Market in Disguise

-- Japan-Holding Its Own

-- Europe-Economic Crisis Drives Reorganization

-- China-The WTO Powerhouse

-- The Lure of Emerging Markets

- India

- Latin America

- East Asia

- IVD Market Growth- Segments and Technologies

-- Traditional IVDs

-- Emerging Tests and Technologies

--- Protein Patterns

--- New Immunoassay Technology

--- New Molecular and Miniaturization Tests and Devices

Chapter Four: Trends in Healthcare Delivery and In Vitro Diagnostics

- Miniaturization and Chip Progress

- Non-Invasive Techniques and Alternative Samples

- Commercialization Issues: Patents and Market Innovation

- Direct to Consumer Marketing

- Patient Management and Outcomes-Based Medicine

- Economics of New Tests and Technologies- The Old Don't Disappear

- Post Genomics and Pharmacogenomics- Reality Check

- Regulatory and Reimbursement Issues and Novel Devices

Chapter Five: Point-of-Care Tests

- Overview

- POC Test Segments

-- Patient Self Tests

-- Professional POC

-- Market Analysis: Leading Suppliers

- Self-Testing Segments

-- Blood Glucose

-- Pregnancy/Ovulation

-- Coagulation/PT

-- Fecal Occult Blood

-- Cholesterol

- Professional Testing Segments

-- Critical Care

-- Cholesterol

-- Coagulation

-- Cardiac Markers

-- Infectious Diseases

-- Cancer Markers

- Institutional Users of POC Tests

- The Commercial Outlook for POC Tests

Chapter Six: Clinical Chemistry

- Overview of Chemistry Tests

- Market Analysis: Leading Suppliers and Growth Potential

-- Suppliers

-- Geographic Markets

-- Segments

--- General Chemistry

--- Blood Gases

--- Urinalysis

- Lab Automation and Work Station Consolidation

- The Commercial Outlook for Chemistry Tests

Chapter Seven: Immunoassays

- Overview of Immunoassays

- Market Analysis: Leading Suppliers and Growth Potential

- Immunoassay Test Segments- Mature, Maturing and Emerging

-- Thyroid Function

-- Therapeutic drug tests

-- Anemia

-- Fertility

-- Tox/DAU

-- Allergy

-- Infectious Diseases

-- Proteins

-- Tumor Markers

-- Cardiac Markers

-- Autoimmune

-- Sepsis

-- Miscellaneous

- Proteins in Post Genomic Medicine

- The Commercial Outlook for Immunoassays

Chapter Eight: Molecular Assays

- Overview

- Market Analysis: Leading Suppliers and Growth Potential

-- Infectious Diseases

-- SNPs, Inherited Diseases, Oncology

--- Thrombophilia-Factor V Leiden, Factor II Prothrombin, MTHFR

--- Cystic Fibrosis

--- Hemochromatosis

--- Gene Methylation

--- Circulating Cell-free Nucleic Acids

--- Ribonucleic Acid (RNA)

-- Prenatal Screening

-- Tissue Typing

- Molecular Testing Initiatives: Technology and Players

- Post Genomic Medicine and the Gene/Protein Mix

- PCR Patents and Innovation

- The Commercial Outlook for Molecular Tests

Chapter Nine: Hematology

- Overview

- Market Analysis: Leading Suppliers and Growth Potential

- Decentralized Hematology Testing

- The Commercial Outlook for Hematology Tests

Chapter Ten: Coagulation

- Overview of Coagulation and Immunohematology Tests

- Market Analysis: Leading Suppliers and Growth Potential

-- Lab-Based Coag

-- Hospital POC

-- Coagulation Self-Testing

- The Commercial Market for Coagulation Tests

Chapter Eleven: Microbiology and Virology

- Overview

- Market Analysis: Leading Suppliers and Growth Potential

-- Supplies

-- Organism Identification and Antimicrobial Resistance Testing (ID/MIC)

-- Blood Culture

-- Rapid Tests

- Antimicrobial Resistance-A Moving Target

- Tradition Is Challenged by Molecular Techniques

- Emerging Organisms and the Globalization of Infectious Diseases-West Nile, SARS, and Influenza

- The Commercial Outlook for Microbiology / Virology Tests

Chapter Twelve: Blood Banking Services

- Overview

- World Blood Banking Developments

- Market Analysis: Leading Suppliers and Growth Potential

-- Blood Grouping

-- Immunoassays

-- Nucleic Acid Testing (NAT) Continues to Grow

- Artificial Blood Products Begin to Appear

- The Commercial Outlook for Blood Banking

Chapter Thirteen: Histology and Cytology

- Overview

- Market Analysis: Leading Suppliers and Growth Potential

-- Traditional Stains

-- Immunohistochemical Stains (IHC) and In Situ Hybridization (ISH)

-- Tissue Microarrays

-- Circulating Tumor Cells

- Genomic Medicine Fuels Histology Pharmacogenomics

- Flow Cytometry on the FLOW

- The Commercial Outlook for Histology and Cytology Tests

Chapter Fourteen: Company Profiles: The Top Tier

- Abbott Labs

- ARKRAY (formerly Kyoto Daiichi)

- Bayer Corporation, Diagnostics Division

- Becton, Dickinson and Company (BD)

- Beckman Coulter Inc.

- bioMerieux Inc.

- Bio-Rad Laboratories Inc.

- Chiron Corporation

- Cytyc Corporation

- Dade Behring Inc.

- Dako A/S

- Diagnostic Product Corporation (DPC)

- Gen-Probe Incorporated

- Instrumentation Laboratory (IL)

- Inverness Medical Innovations, Inc.

- LifeScan Inc.

- Nova Biomedical

- Olympus America Inc.

- Ortho Clinical Diagnostics (OCD)

- Qiagen N.V.

- Radiometer A/S

- Roche Diagnostics

- Sysmex Corporation

- Ventana Medical Systems

Chapter Fifteen: Company Profiles: The Second Tier

- ABAXIS Inc.

- Accumetrics Incorporated

- AcroMetrix Corporation

- Adeza Biomedical, Inc.

- AESKU.Diagnostics GmbH

- Affymetrix Inc.

- Applied Imaging Corp.

- Ambion Diagnostics

- Applied Biosystems Group

- Arcturus Bioscience Inc.

- artus GmbH

- Axis-Shield plc

- Binding Site Inc. (The)

- Biosite Incorporated

- Boule Diagnostics International AB

- B·R·A·H·M·S Aktiengesellschaft

- Caliper Life Sciences, Inc.

- Celera Diagnostics

- Cepheid

- Chempaq A/S

- Cholestech Corporation

- Ciphergen Biosystems, Inc.

- Clarient (formerly ChromaVision Medical Systems, Inc.)

- Clinical Data, Inc. (formerly Novitron International, Inc.)

- Diagnostica Stago

- DiaSorin S.p.A.

- Digene Corporation

- Eiken Chemical Co., Ltd.

- Fujirebio Diagnostics Inc.

- Genzyme Corporation

- Greiner Bio-One International AG

- Hardy Diagnostics

- HemoCue AB

- HemoSense, Inc.

- Hemosystem SA

- Hitachi High-Technologies Corporation.

- Home Diagnostics, Inc.

- Horiba ABX S.A.

- Hypoguard, USA Inc.

- Idaho Technology, Inc.

- Illumina

- Immucor Inc.

- Immunicon Corporation

- Innogenetics

- International Technidyne Corp (ITC)

- Invitrogen Corporation

- IRIS International, Inc.

- i-Stat

- KREATECH Biotechnology B.V.

- Laboratory Corporation of America Holdings (LabCorp)

- Luminex Corporation

- Matritech

- Mayo Medical Laboratories

- Medtronic Diabetes

- Meridian Bioscience, Inc.

- Metrika Inc.

- Micronics, Inc.

- Monogram Biosciences, Inc. (formerly Virologic, Inc.)

- Nanogen Inc.

- OraSure Technologies, Inc.

- Osmetech plc

- Oxford Immunotec Limited

- Oxoid Limited

- Pall Corporation

- Panbio Limited

- Partec GmbH

- PerkinElmer, Inc.

- Phadia AB (formerly Pharmacia Diagnsotics AB)

- Polymedco, Inc.

- Quest Diagnostics Inc.

- Quidel Corporation

- Randox Laboratories Ltd.

- Remel, Inc.

- Sakura Finetek USA Inc.

- Sequenom Inc.

- SIRS-Lab GmbH

- Specialty Laboratories/Ameriparth, Inc.

- Stratagene Corporation / Hycor Biomedical Inc.

- TheraSense, Inc.

- Third Wave Technologies, Inc.

- Tm Bioscience Corp.

- TOSOH Corporation

- Trinity Biotech plc

- TriPath Imaging, Inc.

- Wako Pure Chemical Industries, Ltd.

Chapter Sixteen: Company Profiles: The Third Tier

- 454 Life Sciences

- ABTECH Scientific, Inc.

- Accelr8 Technology Corp.

- Acolyte Biomedica Ltd

- Acrongenomics Inc.

- Adaltis Inc.

- ADIATEC

- Addison-Davis Diagnostics, Inc. (ADDI)

- Adlyfe, Inc.

- AdnaGen AG

- Advalytix AG

- Advanced Biological Laboratories SA (ABL)

- Advance Nanotech, Inc.

- Advanced Analytical Technologies Inc.

- AdvanDx, Inc.

- Aerocine AB

- Agencourt Bioscience Corporation

- Agendia B.V.

- Akers Biosciences, Inc.

- Alpco Diagnostics

- Alopex GmbH

- Ambry Genetics

- AMDL, Inc.

- American Bio Medica Corporation

- American Diagnostica Inc. (ADI)

- Amnis Corporation

- Animas Corporation

- ANP Technologies, Inc.

- Aphton Corporation

- Applied NeuroSolutions, Inc.

- Ark Therapeutics Limited

- Assay Designs, Inc.

- Associates of Cape Cod, Inc.

- Attogenix Biosystems Pte Ltd

- AusAm Biotechnologies, Inc.

- AutoGenomics, Inc.

- Avitar, Inc.

- AVIVA Biosciences

- Bacterial Barcodes Inc.

- Banyan Biomarkers

- Baxter Healthcare Corporation

- bcs BIOTECH S.p.A.

- Bedfont Scientific Ltd

- Bender MedSystems GmbH

- BioArray Solutions, Ltd.

- Biocept, Inc.

- BioCurex, Inc.

- BioGenex Laboratories

- Biohit Plc.

- Bio-Layer Corporation Ltd.

- Biolog Inc.

- bioLytical Laboratories Inc.

- Biomarker Technologies LLC

- Biomedical Diagnostics, LLC

- Biomerica Inc.

- Biomoda Inc.

- Bionomics Limited

- Biophage Pharma Inc.

- Biophysical Corporation

- BioPredictive S.A.S

- Biosafe Medical Technologies, Inc.

- Biotools, B & M Labs, S.A.

- BioVeris Corporation

- BIOVIEW, Inc.

- BioVisioN AG

- Bmd, Biomedical Diagnostics

- Boditech Med Inc.

- Bruker Biosciences Corporation

- CCC Diagnostics LLC

- Calypte Biomedical Corporation

- Cancer Genetics Inc.

- Cangen Biotechnologies, Inc.

- Celerus Diagnostics

- CellaVision AB

- Cellestis Ltd.

- CeMines, Inc.

- Chembio Diagnostics, Inc.

- ChemGenex Pharmaceuticals Limited

- Chemicon International, Inc.

- ChemSensing, Inc.

- China Medical Technologies, Inc.

- ChondroGene Limited

- Cis Biotech, Inc.

- CLONDIAG chip technologies GmbH

- co.don Tissue Engineering, Inc.

- CombiMatrix Corporation

- Competitive Technologies, Inc.

- CompuCyte

- Corgenix Medical Corporation

- Correlagen Diagnostics, Inc.

- Correlogic Systems, Inc.

- Cortex Biochem Inc.

- C.S.F. srl

- Cygnus Inc.

- Cylex Incorporated

- CytoCore Inc. (formerly Molecular Diagnostics, Inc.)

- Daiichi Pure Chemicals Co., Ltd.

- DexCom Inc.

- Diabetech, LP

- Diabetes Sentry Products Inc.

- diaDexus, Inc.

- DiagnoCure Inc.

- Diagnostic Chemicals Ltd (DCL)

- Diagnostic Systems Laboratories Inc. (DSL)

- Diaglobal GmbH

- Diamedix Corporation/Ivax Diagnostics

- DiaSys Corporation

- Diazyme Laboratories

- Digital Bio Technology/ InCyto

- DMetrix, Inc.

- DNA Bioscience

- DNA Direct, Inc.

- DNAPrint genomics, Inc.

- DxS Ltd.

- Dynal Biotech ASA

- Dynex Technologies

- eGene Inc.

- Enzo Biochem, Inc.

- Epigenomics AG

- Epitome Biosystems

- Epoch Biosciences, Inc.

- Equal Diagnostics

- EraGen Biosciences Inc.

- EXACT Sciences Corporation

- Exagen Diagnostics, Inc.

- Exiqon A/S

- FALCO biosystems Ltd.

- Focus Diagnostics, Inc. (formerly Focus Technologies)

- Fujifilm Diagnostics (Fujifilm GmbH)

- GEN ID Lab Services Inc.

- Genaco Biomedical Products, Inc.

- Genaissance Pharmaceuticals, Inc.

- GenBio

- Genekam Biotechnology AG

- Genelex Corporation

- GeneOhm Sciences, Inc.

- Generex Biotechnology Corporation

- GenoID Ltd.

- GenoMed, Inc.

- Genomic Health, Inc.

- Genomic Profiling Systems (GPS)

- Genoptix Inc.

- GENPOINT AS

- Gentra Systems Inc.

- Gentris Corporation

- Geron Corporation

- Global Detection & Reporting, Inc. (GDR)

- GlucoLight Corporation

- Glucon Medical Ltd

- Glycominds Ltd.

- Grant Life Sciences Inc.

- Grifols S.A.

- Guava Technologies, Inc.

- GW Medical Technologies LLC

- Gyros AB

- Hamilton Thorne Biosciences, Inc.

- HealthCheckUSA

- Healthy Estrogen.com, Inc.

- Hema Diagnostic Systems, LLC

- HistoRx, Inc.

- IBEX Technologies Inc.

- Ibis Technologies

- IBL-America

- Identa Corporation

- Ikonisys, Inc.

- Innotrac Diagnostics Oy

- Innovative Biosensors, Inc. (IBI)

- Insulet Corporation

- InterGenetics Incorporated

- IntraCellular Diagnostics, Inc.

- Invirion Inc.

- IPGDx

- Ipsogen

- Integrated Nano-Technologies, LLC (INT)

- Integrated Sensing Systems, Inc. (ISSYS)

- IntegraGen SA

- IQuum Inc.

- Isotechnika Inc.

- amiya Biomedical Co.

- KineMed, Inc.

- Knopp NeuroSciences Inc.

- KRONUS Inc.

- LGM International Inc

- LifeSpan BioSciences

- Lifestream Technologies

- LightUp Technologies AB

- LipoScience, Inc.

- Luminous Medical Inc.

- MacoPharma SA

- Magellan Biosciences

- MAST GROUP Ltd.

- MedCap Corp.

- Medical Services International Inc.

- Medical Wire & Equipment Co. (MW&E)

- MedMira Inc.

- Medicorp Inc.

- MelTec GmbH & Co. KG

- A. Menarini Diagnostics

- Menssana Research

- Metabolon, Inc.

- MetriGenix Corporation

- MicroFluidic Systems Inc. (MFSI)

- Milenia Biotec GmbH

- Milestone Medical

- Millipore Corporation

- Miraculins Inc.

- J. Mitra & Co. Pvt. Ltd.

- Mobidiag Oy

- Mobious Genomics Ltd.

- Molecular Probes

- Molzym GmbH & Co.

- Monogen, Inc.

- Mossman Associates, Inc.

- Nanobac Life Sciences, Inc.

- NanoLogix, Inc. (formerly Infectech Inc.)

- Nanosphere Inc.

- The National Center for Genome Resources (NCGR)

- N-Dia, Inc.

- NetImpact Holdings, Inc.

- NIR Diagnostics Inc.

- NTD Laboratories

- Nymox Pharmaceutical Corporation

- OncoMethylome Sciences S.A.

- One Cell Systems, Inc.

- Orchid Biosciences, Inc.

- ORGENTEC Diagnostika GmbH

- Orion Genomics

- Orpegen Pharma

- Oxford Biosensors Ltd.

- OXIS International Inc.

- Oxonica plc

- ParAllele Bioscience, Inc.

- PathWork Informatics Inc.

- Pelikan Technologies Inc.

- Perceptronix Medical Inc.

- Pharmanetics, Inc.

- Philips Medical Systems

- Phoenix Bio-Tech Corp

- PlaCor, Inc.

- PointCare Technologies, Inc.

- Polymer Technology Systems, Inc.

- PortaScience, Inc.

- Power3 Medical Products, Inc.

- PreAnalytiX GmbH

- PrecisionMed Inc.

- Predicant Biosciences Inc. (formerly Biospect Inc.)

- Predictive Diagnostics, Inc.

- PreMD Inc. (formerly IMI International Medical Innovations, Inc.)

- Primagen Holding B.V.

- Princeton BioMeditech Corporation

- Prodesse Inc.

- Progenika Biopharma, S.A.

- PrognostiX Inc.

- Pro-Lab Diagnostics

- Proteome Systems Ltd

- Provalis Diagnostics

- pSivida Limited

- QuantomiX Ltd.

- Raman Systems Inc. (RSI)

- Relative Genetics

- Rennesens GmbH

- Renovar, Inc.

- Repromedix Corp.

- Response Biomedical Corp.

- Rubicon Genomics, Inc.

- Saliva Diagnostic Systems , Inc. (SDS)

- ScheBo-Biotech AG

- Schleicher & Schuell BioScience, Inc.

- Sciperio Inc.

- Sepal Reproductive Devices

- Separation Technology Inc.

- Sequella Incorporated

- Seryx LLC

- Shenzhen PG Biotech Co Ltd (PG Biotech)

- Siemens AG

- Signet Laboratories Inc. 1

- Silex Microsystems

- Smiths Medical MD, Inc. (formerly Deltec, Inc.)

- SomaLogic, Inc.

- Sontra Medical Corporation

- Source MDx

- Spectral Diagnostics Inc.

- Sphere Medical Ltd.

- STMicroelectronics

- Suracell Inc.

- SureScreen Diagnostics, Ltd.

- Synova Healthcare, Inc.

- Takara Bio Inc.

- Targeted Diagnostics & Therapeutics, Inc. (TDT)

- TECHLAB Inc.

- Tessera Diagnostics

- Theranostech, Incorporated

- ThyroTec, Inc.

- TREK Diagnostic Systems, Inc.

- Trillium Diagnostics, LLC

- United Biotech, Inc. (UBI)

- U.S. Genomics

- Veredus Laboratories Pte

- Veridex LLC

- VIRCO BVBA

- Vision BioSystems Ltd.

- Vita Genomics

- WaveSense LLC

- WayPoint Biomedical, Inc.

- Whatman Inc.

- Xact Aid, Inc.

- XDx Inc.

- Xenomics, Inc.

- York Nutritional Laboratories

- Zila, Inc.

- Zonda, Inc.

- Zymed Laboratories Inc.

- ZymeQuest, Inc.

To order this report:

The Worldwide Market for In Vitro Diagnostic Tests, 6th Edition

http://www.reportlinker.com/p087188/The-Worldwide-Market-for-In-Vitro-Diagnostic-Tests-6th-Edition.html

More market research reports here!

Contact Information